Improving Science & Restoring Trust in Public Health | Dr. Jay Bhattacharya
Dr. Jay Bhattacharya, MD, PhD, Director of the NIH, discusses the NIH's mission, funding challenges, the replication crisis, and restoring public trust in science. He addresses the COVID-19 pandemic response, drug pricing, and a new initiative to investigate autism's etiology.
Deep Dive Analysis
18 Topic Outline
NIH Mission and Funding Basic vs. Applied Research
Indirect Costs (IDC) and University Funding Distribution
Taxpayer Funding, Journal Access, and Drug Costs
Reducing Medication Prices and Global R&D Burden
Scientific Groupthink and Grant Review Process
Challenges for Early Career Scientists and Innovation
Careerism in Science and Intolerance to Failure
The Replication Crisis and Incentives in Science
Addressing Data Fraud and Pro-Social Scientific Behavior
NIH Grant Priorities: DEI, Identity, and Scientific Merit
Public Trust in Science and COVID-19 Pandemic Response
Lockdowns, Mask Mandates, and Their Societal Harms
Academic Ostracism and Public Health Messaging Failures
Culture of American Science: Discourse and Disagreement
COVID-19 Vaccines: Efficacy, Harms, and Mandates
Long-Term Vaccine Effects and Long COVID
Investigating Vaccines and the Rise in Autism
NIH Initiative on Autism Etiology and Future Restructuring
9 Key Concepts
Basic Science
Research focused on making fundamental discoveries without a specific treatment or disease in mind, providing the knowledge base from which all treatments and cures are eventually made. This type of work is often not patentable by private companies.
Applied Science
Research that takes basic scientific advances and translates them into specific treatments, drugs, or products for diseases. This often involves preclinical and clinical trials, and the private sector has incentives to fund later stages due to patent potential.
Indirect Costs (IDC)
A percentage of federal research grants, in addition to the direct costs, paid to universities to cover fixed research infrastructure expenses like buildings, maintenance, and administrative support. The current structure concentrates federal support in a select few universities.
Bayh-Dole Act
A law passed in the mid-1980s that allows universities and small businesses to retain ownership of inventions made with federal funding. Its purpose was to incentivize the commercialization of basic research into products that benefit the public, addressing a 'last mile problem'.
Replication Crisis
The inability to reproduce or verify certain scientific findings, particularly in biomedical literature, leading to a lack of reliability in published research. It is often driven by incentives that reward novel, statistically significant results over replication or reporting negative findings.
H-index
A metric used to quantify a scientist's productivity and influence, based on the number of papers published and the number of citations each paper receives. It can incentivize volume and influence over honesty about failures or pro-social behavior in science.
Inductive vs. Deductive Science
Inductive science involves making observations to generate hypotheses, often descriptive, such as gene sequencing. Deductive science involves testing specific hypotheses that are, in principle, falsifiable through experimentation.
DEI (Diversity, Equity, Inclusion)
An ideology, as described by Dr. Bhattacharya, that emphasizes race essentialism, suggesting that one's race is the primary defining characteristic, and that structural racism is the main cause of health disparities. This is distinguished from legitimate scientific inquiry into health outcomes of minority populations.
Unanimity of Messaging
An ethical norm sometimes adopted in public health that prioritizes consistent and unified communication to the public, often to ensure compliance with health directives. This approach can conflict with the scientific norm of free speech and open discourse, potentially undermining public trust if messaging is not fully rooted in science.
11 Questions Answered
The essential mission of the NIH is to support research that advances the health and longevity of the American people, and by extension, the entire world, by funding both basic and applied biomedical science.
American taxpayers often pay 2 to 10 times more for the same drugs, partly because U.S. health insurers and drug companies use these higher prices to fund the expensive late-stage research and development efforts for new products, effectively making Americans the primary funders of global pharmaceutical R&D.
The current system, particularly through indirect costs linked to grant success, concentrates federal support in a few top universities, incentivizes incremental 'safe' research over bold, high-risk ideas, and discourages early-career scientists from pursuing novel, potentially field-changing work due to fear of failure.
The replication crisis refers to the alarming unreliability of much of the published biomedical literature, where many findings are difficult or impossible to reproduce. This is often due to scientific difficulty and incentives that favor publishing novel, statistically significant results over verifying existing ones or reporting negative findings.
The NIH plans to make replication a viable career path by offering large grants for such work, establish a high-profile journal for publishing replication and negative results, and measure pro-social behaviors like data sharing and cooperation in replication efforts as part of scientific productivity metrics.
The shift aims to refocus the NIH portfolio away from purely ideological concepts, such as race essentialism or non-falsifiable theories like 'structural racism causes health problems,' and back towards funding scientific hypotheses that are testable and directly advance the health and longevity of all Americans, regardless of race or background.
Lockdowns, especially school closures, were a tremendous mistake, causing children (especially minorities) to fall years behind in schooling and leading to widespread economic dislocation, increased deaths of despair (e.g., drug overdoses), and disproportionate harm to the poor and working class, without clear evidence of their necessity or sufficiency in protecting human life.
Public health authorities prioritized a unified message, believing it would ensure public compliance, but this led to the suppression of scientific discourse, vilification of dissenting scientists, and the promotion of policies (like certain mask mandates or vaccine efficacy claims) not fully rooted in science, ultimately eroding public trust.
Dr. Bhattacharya believes that for boys and young men, particularly between ages 12 and 30 with no underlying conditions, the COVID-19 vaccine is likely net harmful, citing evidence of heart inflammation (myocarditis) and a less favorable benefit-harm calculation compared to older populations.
While some studies, particularly a large Danish study on the MMR vaccine, have failed to find a causal link with autism, Dr. Bhattacharya notes that the literature for other vaccines is less clear due to a lack of focused investigation. He believes it's unlikely to be the main reason for the rise in autism but advocates for open-minded scientific inquiry.
The NIH is organizing an initiative to address the question of autism's etiology through an open competition among scientific teams. This will involve wide-ranging, rigorous, gold-standard research, including basic science, epidemiology, and environmental exposure work, in collaboration with autistic parents and the autism community, without pre-emphasizing any particular hypothesis.
16 Actionable Insights
1. Prioritize Scientific Truth Over Hierarchy
Cultivate a mindset that values scientific truth above hierarchical authority. Seek out and support scientific environments where open dissent and rigorous debate are encouraged, rather than obedience to established figures.
2. Foster Honest Scientific Communication
Demand transparency from scientific and public health authorities. Prioritize information that honestly articulates what is known and unknown, treating the public as informed partners rather than subjects to be managed, which builds trust.
3. Demand Scientific Accountability
Expect and advocate for the scientific community to openly acknowledge mistakes and engage in self-correction. This transparency is vital for rebuilding public trust and ensuring more effective responses to future health crises.
4. Evaluate Public Health Messaging Critically
Critically assess public health recommendations, especially if they appear illogical or lack clear scientific grounding. Recognize that messaging not rooted in robust evidence can erode trust and potentially lead to suboptimal personal health decisions.
5. Evaluate Vaccines Evidence-Based
Approach vaccine decisions with an evidence-based mindset, carefully weighing benefits and harms through rigorous data, including randomized studies. Avoid moralizing vaccine choices, acknowledging that suitability can vary based on individual circumstances and scientific nuance.
6. Skepticism of Published Research
Maintain a healthy skepticism towards published biomedical literature, as much of it may not be reliably true due to inherent scientific challenges and current incentive structures. Seek out findings that have been independently replicated for greater confidence.
7. Prioritize Young Scientists & Bold Ideas
Understand that supporting early career scientists and bold, high-risk research is crucial for transformative discoveries. Advocate for funding models that reduce the pressure for incremental work and sharp penalties for failure, fostering innovation.
8. Support Replication Science
Recognize the critical importance of replication studies and meta-analyses in verifying scientific findings. Support initiatives that make assessing the truth and reliability of scientific literature a respected and funded endeavor.
9. Utilize New NIH Replication Journal
Be aware that the NIH will launch a new journal specifically for publishing replication studies and negative results. Use this resource to easily search for and evaluate the robustness of scientific claims.
10. Value Pro-Social Scientific Behavior
Understand that the NIH is shifting incentives to reward pro-social scientific behaviors, such as open data sharing, cooperation in replication efforts, and publishing negative results. This aims to foster a culture prioritizing truth and reliability over mere publication volume or influence.
11. Support Open Autism Etiology Research
Be aware of the new NIH initiative to broadly investigate the etiology of autism, including basic science, epidemiology, and environmental factors, without predetermined hypotheses. This open-minded approach seeks to provide comprehensive answers for affected families.
12. Combat Scientific Groupthink
Advocate for and support the geographic and intellectual dispersion of scientific funding and institutions. This strategy helps to combat groupthink by encouraging diverse perspectives and fostering richer scientific discourse.
13. Understand Drug Price Disparity
Inform yourself about how American taxpayers disproportionately fund global drug research and development through higher domestic drug prices. This understanding can empower you to engage in discussions about equitable R&D burden sharing.
14. Demand Efficacy for Boosters
Note that the FDA now requires COVID booster shots to demonstrate clinical efficacy (preventing COVID, deaths, hospitalizations) in humans for approval, a higher standard than antibody production alone. This informs expectations for future vaccine evaluations.
15. Access NIH-Funded Research Free
Starting July, take advantage of the new policy allowing free public access to all NIH-funded scientific papers. This enables direct access to research findings that American taxpayers have already supported.
16. Embrace Robust Scientific Discourse
Cultivate an appreciation for scientific progress that emerges from robust and sometimes argumentative discourse. Understand that such open debate, when focused on truth, is essential for advancing knowledge.
8 Key Quotes
If the American taxpayer pays for the research, why shouldn't the American taxpayer be able to read the research for free? Because they already paid for it.
Jay Bhattacharya
The published, peer-reviewed biomedical literature is not reliable, is the bottom line. So a lot of the things that we think we know, even with some fair degree of certainty, are probably not true.
Jay Bhattacharya
The problem of fraud in science, then, is a symptom of the broader problem of the replication crisis rather than the main driver of it.
Jay Bhattacharya
The structure of incentives we've created produced those behaviors. We created them.
Jay Bhattacharya
The lockdowns were a luxury of the laptop class.
Jay Bhattacharya
Essentially, we created a class of unclean people as a matter of public policy.
Jay Bhattacharya
If you are in favor of vaccines, you should not be treating this as a religious matter where vaccine is good, therefore – and you believe that, therefore, you're a good person. Vaccine is bad, therefore, if you believe that, you're a bad person.
Jay Bhattacharya
The way forward isn't to force people to say, look, you must acknowledge how great science is on these other things. The way forward is to be utterly honest about what we know and don't know and treat people as partners rather than as subjects.
Jay Bhattacharya
1 Protocols
Reforming Science to Address Replication Crisis and Promote Truth
Jay Bhattacharya- Make engaging in replication work a viable career path by offering large grants for creative, scalable replication efforts.
- Establish a high-profile NIH journal to publish replication results and negative findings, making them searchable and discoverable to the scientific community.
- Measure pro-social behaviors by scientists (e.g., data sharing, cooperation in replication, engaging in replication efforts) and include these in the suite of statistics used to evaluate scientific productivity, alongside publication volume and influence.